Synaptive Medical Secures Strategic Investment to Accelerate Growth and Innovation
'We remain deeply committed to investing in the people, tools, and technologies that drive progress in surgical planning, neuro-navigation, robotic exoscopy, and advanced MRI,' said Cameron Piron, President and Founder of Synaptive Medical. 'From enhancing surgical precision with our integrated robotic and navigation systems to expanding the diagnostic potential of our MRI platforms, Synaptive is redefining the future of surgery—from imaging to intervention.'
As part of its transformation, Synaptive is reaffirming its commitment to its comprehensive product portfolio. The company will continue to expand its integrated surgical suite—including Modus X™, Modus Nav™, and Modus Plan™ —alongside its dedicated MRI platform. These advancements are closely aligned with long-standing partnerships at leading hospitals and clinical institutions around the world.
Throughout the restructuring, Synaptive maintained uninterrupted customer support while continuing to execute on its innovation roadmap. Recent milestones include major software upgrades across its platforms and the launch of new collaborations with internationally recognized medical centers in the United States and Europe.
The newly secured investment will bring the company to profitability and reflects strong confidence in Synaptive's strategic direction and long-term growth. The company has been wholly acquired by a mission-aligned consortium of MedTech executives, clinicians, and experienced investors who bring deep domain expertise and a shared vision for the future of neurosurgical care.
'This investment represents a powerful recommitment to Synaptive's mission: to transform brain health in the 21st century for patients and families in need,' said Dr. Joshua Bernstock, neurosurgeon and incoming board member. 'We're proud to join forces with a team that is not only passionate about elevating the standard of care but also fearless in pushing the boundaries of what's possible in diagnostics and surgical innovation.'
This investment represents the first phase of a broader capital initiative, with additional funding expected in the coming weeks to further support Synaptive's growth strategy and accelerate its innovation pipeline.
About Synaptive Medical
Synaptive Medical Inc. is a Toronto-based global medical technology company dedicated to solving complex challenges in surgery, imaging, and data integration to improve patient outcomes. Its integrated suite of solutions—spanning MRI, surgical planning, navigation, and robotic visualization—delivers intelligent, patient-centric technology that enhances clinical decision-making and efficiency across every stage of neurosurgical care.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
21 minutes ago
- Business Wire
KIOXIA AiSAQ™ Software Advances AI RAG with New Version of Vector Search Library
TOKYO--(BUSINESS WIRE)--In an ongoing effort to improve the usability of AI vector database searches within retrieval-augmented generation (RAG) systems by optimizing the use of solid-state drives (SSDs), Kioxia Corporation, a world leader in memory solutions, today announced an update to its KIOXIA AiSAQ™ (All-in-Storage ANNS with Product Quantization) software. This new open-source release introduces flexible controls allowing system architects to define the balance point between search performance and the number of vectors, which are opposing factors in the fixed capacity of SSD storage in the system. The resulting benefit enables architects of RAG systems to fine tune the optimal balance of specific workloads and their requirements, without any hardware modifications. First introduced in January 2025, KIOXIA AiSAQ software uses a novel approximate nearest neighbor search (ANNS) algorithm that is optimized for SSDs and eliminates the need to store index data in DRAM. By enabling vector searches directly on SSDs and reducing host memory requirements, KIOXIA AiSAQ technology allows vector databases to scale, largely without the restrictions caused by limited DRAM capacity. When the installed capacity of the SSD in the system is fixed, increasing search performance (queries per second) requires more SSD capacity consumed per vector. This results in a smaller number of vectors. Conversely, to maximize the number of vectors, SSD capacity consumption per vector needs to be reduced, which results in lower performance. The optimal balance between these two opposing conditions varies depending on the specific workload. To find the appropriate balance, KIOXIA AiSAQ software introduces flexible configuration options. This latest update allows administrators to select the optimal balance for a variety of contrasting workloads among the RAG system. This update makes KIOXIA AiSAQ technology a suitable SSD-based ANNS for not only RAG applications but also other vector-hungry applications such as offline semantic searches. With growing demand for scalable AI services, SSDs offer a practical alternative to DRAM for managing the high throughput and low latency that RAG systems require. KIOXIA AiSAQ software makes it possible to meet these demands efficiently, enabling large-scale generative AI without being constrained by limited memory resources. By releasing KIOXIA AiSAQ software as open-source, Kioxia reinforces its commitment to the AI community with the promotion of SSD-centric architectures for scalable AI. Please follow the link to download KIOXIA AiSAQ open-source software. * KIOXIA AiSAQ: All-in-Storage ANNS with Product Quantization, a novel method of index data placement, is a trademark of Kioxia. * All other company names, product names and service names may be trademarks of third-party companies. About Kioxia Kioxia is a world leader in memory solutions, dedicated to the development, production and sale of flash memory and solid-state drives (SSDs). In April 2017, its predecessor Toshiba Memory was spun off from Toshiba Corporation, the company that invented NAND flash memory in 1987. Kioxia is committed to uplifting the world with 'memory' by offering products, services and systems that create choice for customers and memory-based value for society. Kioxia's innovative 3D flash memory technology, BiCS FLASH™, is shaping the future of storage in high-density applications, including advanced smartphones, PCs, automotive systems, data centers and generative AI systems. *Information in this document, including product prices and specifications, content of services and contact information, is correct on the date of the announcement but is subject to change without prior notice.
Business Upturn
an hour ago
- Business Upturn
Alembic Pharma acquires UK-based Utility Therapeutics for $12 million to expand US presence
Alembic Pharmaceuticals Inc., the wholly owned US subsidiary of Alembic Pharmaceuticals Limited, has announced the acquisition of UK-based Utility Therapeutics Ltd. This strategic move marks Alembic's entry into the branded anti-infective segment in the United States, particularly focusing on treatments for urinary tract infections (UTIs). Utility Therapeutics is engaged in developing pharmaceutical products aimed at combating UTIs, a widespread medical condition in the US. The acquisition brings two key assets into Alembic's fold — 'Pivya,' an FDA-approved treatment for uncomplicated UTIs, and 'MEC,' a pipeline product currently under development to address complicated UTI cases. Alembic Pharmaceuticals sees this acquisition as a significant step towards strengthening its presence in the US market with branded specialty products. The deal allows Alembic to market Utility's assets in the US, leveraging the regulatory approvals already in place and continuing the development of promising pipeline therapies. The total consideration for the acquisition is expected to be around $12 million, paid in a staggered manner depending on the achievement of specific milestones. It also includes a provision for profit sharing based on future earnings generated by Utility's products. The transaction does not fall under the related party category, and none of the promoters or group companies have any financial interest in the deal. Completion of the acquisition is anticipated within approximately 30 days, and no additional regulatory approvals are required. This acquisition aligns with Alembic's strategy of expanding its global footprint and diversifying its product offerings in regulated markets like the US. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Yahoo
2 hours ago
- Yahoo
Rogers Officially Becomes Majority Owner Of Maple Leaf Sports & Entertainment
The parent company of the Toronto Maple Leafs and Marlies has a new majority owner. Rogers Communications closed the deal on July 1 to buy BCE's 37.5 percent stake in Maple Leaf Sports & Entertainment. It became the majority owner of the company that also owns the NBA's Toronto Raptors, CFL's Toronto Argonauts and MLS' Toronto FC. Advertisement Rogers announced in June it received all league approvals to buy the stake of BCE, the holding company of Bell Canada, and approval from Canada's Competition Bureau. At the time, it awaited approval from the Canadian Radio-television and Telecommunications Commission to acquire "an additional indirect interest in Toronto Raptors Network Ltd." Now, Rogers received all necessary approvals to acquire the stake for $4.7 billion Cdn. 'MLSE is one of the most prestigious sports and entertainment organizations in the world and we're proud to be the majority owner of these iconic sports teams,' Tony Staffieri, president and CEO of Rogers, said in a news release on July 2. 'Live sports are a core part of our business and core to the fans who live and breathe every moment.' Edward Rogers, the executive chair of Rogers Communications, told The Hockey News publisher-owner W. Graeme Roustan in January that becoming the majority owner speaks to Rogers' commitment to the Maple Leafs. Advertisement "Our track record is a track record of good ownership in everything we do," Rogers said in the interview for the 2025 Money & Power Issue. "We up our investments. You look at MLSE, we've won a few championships, and the vast majority of profits that MLSE makes go back into the business, back into player salaries." Image Rogers Communications is also the sole owner of MLB's Toronto Blue Jays. "With the Toronto Blue Jays, we're consistently within the top 10 in terms of payroll in the league," Rogers said. "We recently invested upwards of half a billion dollars in the Rogers Centre stadium to increase the fan experience. So, we're very much investors. Ultimately, we want winning teams, and we need to invest to do that, and we know that." Advertisement The executive chairman also said winning teams increase viewership and value, so they're aligned with fans on the desire for squads that capture championships. In April, the NHL and Rogers announced a new 12-year Canadian TV deal that begins after their current 12-year deal ends after the 2025-26 campaign. The Graeme Roustan Show: Edward Rogers And Tony Staffieri The Graeme Roustan Show: Edward Rogers And Tony Staffieri Edward Rogers, the executive chairman of Rogers Communications, and Tony Staffieri, the president-CEO of Rogers Communications, discuss their backgrounds in hockey, why the Rogers company wanted to invest in the Maple Leafs and when a Stanley Cup is coming to Toronto. Advertisement The Maple Leafs finished first in their division for the second time in five seasons and third time in 25 seasons, with 108 points. They advanced past the first round of the playoffs for the second time in 21 years but lost in the second round to the Florida Panthers, which went on to win their second straight Stanley Cup championship. The Marlies, meanwhile, made a first-round appearance in the AHL playoffs. Get the latest news and trending stories by following The Hockey News on Google News and by subscribing to The Hockey News newsletter here. And share your thoughts by commenting below the article on
